{"id":"https://openalex.org/W2064065679","doi":"https://doi.org/10.1002/ddr.430160104","title":"Pentylenetetrazole\u2010like stimulus is produced in rats during withdrawal from ingested chlordiazepoxide","display_name":"Pentylenetetrazole\u2010like stimulus is produced in rats during withdrawal from ingested chlordiazepoxide","publication_year":1989,"publication_date":"1989-01-01","ids":{"openalex":"https://openalex.org/W2064065679","doi":"https://doi.org/10.1002/ddr.430160104","mag":"2064065679"},"language":"en","primary_location":{"id":"doi:10.1002/ddr.430160104","doi":"https://doi.org/10.1002/ddr.430160104","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430160104","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016731387","display_name":"Smart O. Idemudia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Smart O. Idemudia","raw_affiliation_strings":["Department of Pharmacology, Texas College of Osteopathic Medicine, Fort Worth, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Texas College of Osteopathic Medicine, Fort Worth, Texas","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5110161036","display_name":"Harbans Lal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Harbans Lal","raw_affiliation_strings":["Department of Pharmacology, Texas College of Osteopathic Medicine, Fort Worth, Texas"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, Texas College of Osteopathic Medicine, Fort Worth, Texas","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5110161036"],"corresponding_institution_ids":[],"apc_list":{"value":3980,"currency":"USD","value_usd":3980},"apc_paid":null,"fwci":0.5035,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.55635237,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"16","issue":"1","first_page":"23","last_page":"29"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7695000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.7695000171661377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.10490000247955322,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10043","display_name":"Substance Abuse Treatment and Outcomes","score":0.040699999779462814,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chlordiazepoxide","display_name":"chlordiazepoxide","score":0.9079999923706055},{"id":"https://openalex.org/keywords/benzodiazepine-withdrawal","display_name":"benzodiazepine withdrawal","score":0.9739999771118164},{"id":"https://openalex.org/keywords/pentylenetetrazole","display_name":"pentylenetetrazole","score":0.9290000200271606},{"id":"https://openalex.org/keywords/anxiogenic-effects","display_name":"anxiogenic effects","score":0.5759999752044678},{"id":"https://openalex.org/keywords/flumazenil","display_name":"flumazenil","score":0.7799999713897705},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.8320000171661377},{"id":"https://openalex.org/keywords/benzodiazepine-receptor","display_name":"benzodiazepine receptor","score":0.8370000123977661},{"id":"https://openalex.org/keywords/subjective-drug-effects","display_name":"subjective drug effects","score":0.5569999814033508},{"id":"https://openalex.org/keywords/discrimination-learning","display_name":"discrimination learning","score":0.5070000290870667},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.47699999809265137}],"concepts":[{"id":"https://openalex.org/C2778325228","wikidata":"https://www.wikidata.org/wiki/Q178566","display_name":"Chlordiazepoxide","level":3,"score":0.972016453742981},{"id":"https://openalex.org/C2778409475","wikidata":"https://www.wikidata.org/wiki/Q421920","display_name":"Flumazenil","level":4,"score":0.8731299638748169},{"id":"https://openalex.org/C2777397205","wikidata":"https://www.wikidata.org/wiki/Q275792","display_name":"Saline","level":2,"score":0.7352224588394165},{"id":"https://openalex.org/C2778173252","wikidata":"https://www.wikidata.org/wiki/Q83871","display_name":"Benzodiazepine","level":3,"score":0.619565486907959},{"id":"https://openalex.org/C205044023","wikidata":"https://www.wikidata.org/wiki/Q4778117","display_name":"Anxiogenic","level":4,"score":0.5372853875160217},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5359341502189636},{"id":"https://openalex.org/C107524782","wikidata":"https://www.wikidata.org/wiki/Q40164","display_name":"Lever","level":2,"score":0.489641010761261},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.46454834938049316},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.4574851095676422},{"id":"https://openalex.org/C2779918689","wikidata":"https://www.wikidata.org/wiki/Q3771842","display_name":"Stimulus (psychology)","level":2,"score":0.44122740626335144},{"id":"https://openalex.org/C2776175493","wikidata":"https://www.wikidata.org/wiki/Q210402","display_name":"Diazepam","level":2,"score":0.43649372458457947},{"id":"https://openalex.org/C57022672","wikidata":"https://www.wikidata.org/wiki/Q7617378","display_name":"Stimulus control","level":3,"score":0.430886447429657},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.401636004447937},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.31269848346710205},{"id":"https://openalex.org/C2777765862","wikidata":"https://www.wikidata.org/wiki/Q62903","display_name":"Anxiolytic","level":3,"score":0.2143147885799408},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21381357312202454},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.13102373480796814},{"id":"https://openalex.org/C62520636","wikidata":"https://www.wikidata.org/wiki/Q944","display_name":"Quantum mechanics","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C542102704","wikidata":"https://www.wikidata.org/wiki/Q183257","display_name":"Psychotherapist","level":1,"score":0.0},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/ddr.430160104","doi":"https://doi.org/10.1002/ddr.430160104","is_oa":false,"landing_page_url":"https://doi.org/10.1002/ddr.430160104","pdf_url":null,"source":{"id":"https://openalex.org/S26306840","display_name":"Drug Development Research","issn_l":"0272-4391","issn":["0272-4391","1098-2299"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Drug Development Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337347","display_name":"National Institute on Drug Abuse","ror":"https://ror.org/00fq5cm18"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":24,"referenced_works":["https://openalex.org/W1883800065","https://openalex.org/W1936257135","https://openalex.org/W1962066307","https://openalex.org/W1965666249","https://openalex.org/W1976786012","https://openalex.org/W1978342290","https://openalex.org/W1988940178","https://openalex.org/W1989050912","https://openalex.org/W2014017755","https://openalex.org/W2038653980","https://openalex.org/W2041915328","https://openalex.org/W2042011980","https://openalex.org/W2045362803","https://openalex.org/W2051022350","https://openalex.org/W2054571496","https://openalex.org/W2067914882","https://openalex.org/W2078637676","https://openalex.org/W2094152479","https://openalex.org/W2332681242","https://openalex.org/W2421761817","https://openalex.org/W2443548347","https://openalex.org/W2971587151","https://openalex.org/W4229668875","https://openalex.org/W4238517656"],"related_works":["https://openalex.org/W2094152479","https://openalex.org/W2002586608","https://openalex.org/W2421761817","https://openalex.org/W99771674","https://openalex.org/W2080923308","https://openalex.org/W2007295224","https://openalex.org/W2089714088","https://openalex.org/W2058838634","https://openalex.org/W1976645353","https://openalex.org/W2079758453"],"abstract_inverted_index":{"Abstract":[0],"The":[1,134],"present":[2,205],"study":[3],"was":[4,65,71,96,127],"undertaken":[5],"to":[6,79,196],"determine":[7],"whether":[8],"withdrawal":[9,95,194,207],"from":[10,208],"chlordiazepoxide":[11,68,147,159],"administered":[12,72],"via":[13,73],"a":[14,19,30,74,121,190],"liquid":[15,77],"diet":[16,78],"would":[17],"produce":[18],"pentylenetetrazole":[20],"(PTZ)\u2010like":[21],"stimulus.":[22],"Rats":[23],"were":[24,38],"trained":[25],"with":[26,98],"food":[27],"reward":[28],"in":[29],"two\u2010lever":[31],"operant":[32],"task.":[33],"Presses":[34],"on":[35,48,143],"one":[36],"lever":[37,51,141,176,183],"reinforced":[39],"after":[40,52,156],"injections":[41,179],"of":[42,82,92,120,136,146,151,172,193],"PTZ":[43,62,203],"(20":[44],"mg/kg,":[45,132],"i.p.)":[46],"and":[47,67,124,149,180],"the":[49,61,99,111,114,118,139,144,157,161,173,181,200],"other":[50],"saline":[53,174,178],"(1":[54],"ml/kg,":[55],"i.p.).":[56,133],"After":[57],"rats":[58,83,112,137,162],"had":[59,163],"acquired":[60],"discrimination,":[63,166],"training":[64],"halted,":[66],"(240":[69],"mg/kg/day)":[70],"nutritionally":[75],"balanced":[76],"three":[80],"groups":[81],"for":[84],"3,":[85],"4,":[86],"or":[87],"6":[88],"days.":[89],"Upon":[90],"termination":[91],"chronic":[93],"administration,":[94],"precipitated":[97,109],"benzodiazepine":[100],"receptor":[101],"blocker":[102],"flumazenil":[103],"(Ro":[104],"15\u20101788)":[105],"given":[106],"intraperitoneally.":[107],"During":[108],"withdrawal,":[110],"selected":[113],"PTZ\u2010appropriate":[115,140,182],"lever,":[116],"indicating":[117],"presence":[119],"PTZ\u2010like":[122],"stimulus,":[123],"this":[125],"stimulus":[126],"blocked":[128],"by":[129,169,199],"phenobarbital":[130],"(80":[131],"percentage":[135],"selecting":[138],"depended":[142],"duration":[145],"treatment":[148],"dose":[150],"flumazenil.":[152],"At":[153],"10":[154],"days":[155],"last":[158],"dose,":[160],"recovered":[164],"baseline":[165],"as":[167],"indicated":[168],"their":[170],"selection":[171],"appropriate":[175],"following":[177,184],"PTZ.":[185],"These":[186],"data":[187],"indicate":[188],"that":[189,197],"subjective":[191],"effect":[192],"similar":[195],"produced":[198],"anxiogenic":[201],"drug":[202],"is":[204],"during":[206],"oral":[209],"chlordiazepoxide.":[210]},"counts_by_year":[],"updated_date":"2026-08-21T09:56:20.448147","created_date":"2016-06-24T00:00:00"}